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Original Research

Kidney Recovery in Patients With Acute Kidney Injury
Treated in Outpatient Hemodialysis or Rehabilitation
Facilities
Melissa Jordan, Victor Ortiz-Soriano, Aaron Pruitt, Lauren Chism, Lucas J. Liu, Nourhan Chaaban,
Madona Elias, B. Peter Sawaya, Jin Chen, and Javier A. Neyra
Rationale & Objective: Since January 2017, patients with acute kidney injury requiring dialysis
(AKI-D) can be discharged to outpatient dialysis
centers for continued hemodialysis (HD) support.
We aimed to examine the rate of kidney recovery,
time to recovery, and hospitalization-related clinical
parameters associated with kidney recovery in
patients with AKI-D.
Study Design: Single-center prospective cohort
study.
Setting & Participants: 111 adult patients who
were admitted to the University of Kentucky Hospital, experienced AKI-D, and were discharged with
need of outpatient HD.
Exposure: Hospitalization-related clinical parameters were evaluated.
Outcome: Kidney recovery as a composite of being alive and no longer requiring HD or other form
of kidney replacement therapy.
Analytical Approach: Discrete-time survival analysis and logistic regression were used to determine
adjusted probabilities of kidney recovery at prespeciﬁed time points and to evaluate clinical parameters associated with recovery.

Results: 45 (41%) patients recovered kidney
function, 25 (55.5%) within the ﬁrst 30 days
following discharge, 16 (35.5%) within 30 to 60
days, and 4 (9%) within 60 to 90 days. Adjusted
probabilities of recovery were 36.7%, 27.4%, and
6.3%, respectively. Of the remaining patients, 49
(44%) developed kidney failure requiring chronic
kidney replacement therapy and 17 (15%) died or
went to hospice. Patients who did not recover
kidney function were older, had more comorbid
conditions, had lower estimated glomerular ﬁltration rates at baseline, and received more blood
transfusions during hospitalization when compared
with those who recovered kidney function.
Limitations: Selection bias given that patients
included in the study were all eligible for AKI
management with outpatient HD as part of Medicare/Medicaid services.
Conclusions: At least one-third of AKI-D survivors
discharged from an acute care hospital dependent
on HD recovered kidney function within the ﬁrst 90
days of discharge, more commonly in the ﬁrst 30
days postdischarge. Future studies should
elucidate clinical parameters that can inform risk
classiﬁcation and interventions to promote kidney
recovery in this vulnerable and growing population.

A

cute kidney injury (AKI) requiring dialysis (AKI-D)
affects 3% to 20% of hospitalized patients, particularly
those in the intensive care unit (ICU), and carries increased
risk for hospital mortality.1-3 In those who survive the
hospitalization, there is increased risk for chronic kidney
disease (CKD) and cardiovascular disease.4-8 Moreover,

Editorial, p 886
patients who experience AKI-D and deteriorate rapidly to
kidney failure have worse mortality and cardiovascular
disease outcomes when compared with those with CKD
who slowly progress to kidney failure. In contrast, patients
with AKI-D who recover kidney function are less susceptible to these complications.9,10 Currently, there is little
evidence regarding the incidence of kidney recovery in
survivors of AKI-D who are discharged from the hospital to
receive hemodialysis (HD) in outpatient dialysis or rehabilitation facilities.
In January 2017, the Centers for Medicare & Medicaid
Services (CMS) made changes to their policy regarding
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reimbursement for the provision of HD to ambulatory
patients with AKI-D in outpatient dialysis facilities. Before
this policy change, patients with AKI-D continued dialysis
while hospitalized or received dialysis in rehabilitation
facilities or hospital-based dialysis units until kidney recovery or declaration of kidney failure. This was problematic because there was potential for premature
declaration of kidney failure in some patients and
increased risk for adverse outcomes due to prolonged
hospitalization in others. Overall, these patients are
inherently unique compared with their counterparts with
kidney failure receiving maintenance HD and represent a
growing and vulnerable population in outpatient dialysis
centers across the United States.
The main objective of this study was to longitudinally
and systematically examine the incidence of kidney recovery and time to recovery in survivors of AKI-D discharged from the hospital to receive HD in outpatient
dialysis or rehabilitation facilities. We also evaluated
hospitalization-related clinical parameters associated with
kidney recovery.
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PLAIN-LANGUAGE SUMMARY
Since January 2017, patients with acute kidney injury
requiring dialysis (AKI-D) can receive hemodialysis in
outpatient centers after discharge. We studied a cohort
of 111 patients with AKI-D to determine the rate of
kidney recovery, time to recovery, and hospitalizationrelated parameters associated with recovery. At least
one-third of survivors of AKI-D recovered kidney
function within the first 90 days of discharge, more
commonly in the first 30 days postdischarge. Patients
who did not recover kidney function were older, had
more comorbid conditions, had lower baseline kidney
function, and received more blood transfusions during
hospitalization when compared with those who
recovered. Future studies should elucidate clinical parameters that can inform risk classification and interventions to promote kidney recovery in this
vulnerable population.

METHODS
Study Design and Participants
This is a single-center prospective cohort study that
included adult patients 18 years or older who were
admitted to the University of Kentucky Albert B. Chandler
Hospital, experienced AKI-D, and were evaluated to
receive outpatient HD for AKI management in outpatient
dialysis centers or rehabilitation facilities. Patients were
excluded if they had the diagnosis of kidney failure before
hospital admission or before discharge, were recipients of
a kidney transplant, died or elected for hospice care during
their admission, recovered kidney function no longer
needing HD before discharge, or were lost to follow-up
after discharge. The study period was from January 2017
to November 2019.
This study was approved by the Institutional Review
Board (IRB) of the University of Kentucky (IRB # 43540).
Given the observational nature of this investigation,
informed consent was waived by the IRB.
Study Variables and Deﬁnitions

We collected demographic, comorbid condition, acute
illness, and dialysis parameters through automated data
extraction from electronic health records. AKI-D was
defined as the need for any form of kidney replacement
therapy (KRT; eg, HD or continuous KRT) for AKI
management during the hospitalization. We used the
Modification of Diet in Renal Disease Study equation for
calculation of the baseline estimated glomerular filtration
rate.11 Baseline serum creatinine (Scr) level was defined
as the outpatient Scr value closest to 7 days before the
index hospital admission up to 1 year before.12 Only
50.5% of patients had measured baseline Scr levels
available.
Kidney Med Vol 3 | Iss 6 | November/December 2021

The burden of comorbidity was estimated using the
Elixhauser score.13 CKD was defined as having a baseline
estimated glomerular filtration rate < 60 mL/min/1.73
m2. Acute illness parameters such as mechanical ventilation, pressor/inotrope support, and the Sequential Organ
Failure Assessment score14 were obtained for patients
admitted to the ICU. Anemia was defined as having a hematocrit < 39% for men or <36% for women using the
value closest to the hospital admission.15 Nephrotoxin
exposure consisted of receiving the following medications:
nonsteroidal anti-inflammatory drugs, intravascular
contrast, vancomycin, aminoglycosides, daptomycin,
amphotericin B, antineoplastic agents, and/or piperacillin/
tazobactam. Intradialytic hypotension during inpatient HD
was defined as a decrease in systolic blood pressure (BP) ≥
20 mm Hg or in mean arterial pressure ≥ 10 mm Hg from
the initial to the last BP obtained during HD and was
adjusted by the total number of HD sessions received
during the hospitalization.16 Intradialytic hypotension
during continuous KRT was defined as a decrease in systolic BP ≥ 20 mm Hg or in mean arterial pressure ≥ 10 mm
Hg from a dynamic reference BP rolling every 2 hours, and
it was adjusted by the total days of continuous KRT.
Study Outcomes

The primary outcome was kidney recovery, which was a
composite of being alive and no longer requiring HD or
any other form of KRT. This outcome was determined by
the investigative team through telephone calls and reports
from outpatient dialysis or rehabilitation facilities and/or
patients themselves in addition to comprehensive review
of their electronic health records at 30-, 60-, and 90-day
intervals after hospital discharge. A secondary outcome
of all-cause hospital readmissions was also evaluated.
Statistical Analysis

Clinical characteristics were compared between patients
with and without kidney recovery. Continuous data were
reported as mean ± standard deviation or median (interquartile 1-interquartile 3] according to data distribution.
Categorical variables were expressed as percentages.
Continuous data with a normal distribution were
compared using an independent t test, whereas continuous
data that did not exhibit a normal distribution were
compared using a Mann-Whitney U test. A χ 2 test was used
to compare categorical variables. Multivariable logistic
regression was used to evaluate clinical parameters associated with kidney recovery (dependent variable). Covariates with P < 0.1 in the univariable analysis were
included as independent variables in the models. Discretetime survival analysis with the complementary log-log link
were used to estimate the probability of kidney recovery in
each discrete period (0-30, 31-60, and 61-90 days postdischarge). The discrete periods were treated as categorical
variables along with other covariates in the multivariable
model. The recovery probabilities were obtained by the β
917
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Hospitalized adults ≥ 18yo with AKI-D
evaluated for outpa ent HD
n = 196 pa ents
Pa ents excluded (n = 48)
- Kidney failure before or during admission
- Kidney transplant recipient
- AKI-D recovery prior to discharge
- Hospital death or hospice

28
7
8
5

Eligible Cohort
n = 148 pa ents
Pa ents excluded (n = 37)
- Lost to follow-up without any outpa ent data 37
Final Cohort
AKI-D pa ents
n = 111 pa ents

Recovery Group
n = 45 pa ents
(40.5%)

No Recovery Group
n = 66 pa ents
(59.5%)

Figure 1. Cohort derivation. Abbreviations: AKI-D, acute kidney injury requiring dialysis; HD, hemodialysis.

coefficients of the model for each period. A 2-tailed P <
0.05 was considered statistically significant. All statistical
analyses were performed in R programming language (R
Foundation for Statistical Computing).
RESULTS
Clinical Characteristics
A total of 196 patients were evaluated for inclusion/
exclusion criteria and 111 patients were included in the
study cohort (Fig 1). Median age was 59 (interquartile
range [IQR], 47-67) years, 62% were men, and 91% were
White. Median length of hospital stay was 24.3 (IQR,
16.3-36.2) days. Ninety (81%) patients were admitted to
the ICU. Median length of ICU stay was 5.6 (IQR, 2.615.2) days. Mean Elixhauser score was 33.5±11.4. Detailed
clinical characteristics of the whole cohort and after stratification based on kidney recovery status are reported in
Table 1. Sixty-five percent (n = 72) of patients were
ambulatory at discharge and received outpatient HD care in
dialysis facilities while 35% (n = 39) of patients received
initial postdischarge HD care at rehabilitation facilities.

918

Study Outcomes
At the end of the observation period (90 days after
hospital discharge), 45 (41%) patients were alive and
recovered kidney function to be independent of KRT
(kidney recovery group). A total of 17 (15%) patients
died or transitioned to hospice care and 49 (44%) patients were declared to have kidney failure and continued
to receive maintenance HD in outpatient centers (no
recovery group; Fig 2). Among patients who recovered
kidney function, most (25 of 45; 55.5%) did so within
the first 30 days following discharge; 16 of 45 (35.5%),
within 30 to 60 days following discharge; and 4 of 45
(9%), within 60 to 90 days following discharge (Fig 3).
The occurrence of kidney recovery was more frequent in
patients initially receiving HD care at rehabilitation facilities (21/39; 53.8%) versus those in outpatient HD
units (24/72; 33.3%; Fig 4). A total of 16 (14.4%) patients had at least 1 readmission to the hospital in the 90day period following hospital discharge. Hospital readmissions occurred more frequently in patients who did
not recover kidney function versus those who did (75%
vs 25%, respectively).

Kidney Med Vol 3 | Iss 6 | November/December 2021
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Table 1. Patient Characteristics in the Whole Cohort and According to Kidney Recovery

Demographics
Age, y
Sex, male
Race, White
BMI, kg/m2
Comorbidity
Elixhauser score
Diabetes
Hypertension
Stroke
COPD
CAD
Liver disease
CKD
Anemia on admission
Acute illness characteristics
Hospital length of stay, d
ICU admission
ICU length of stay, d
SOFA score at ICU admissiona
Sepsis
Mechanical ventilationa
Nephrotoxins exposure
No. of pRBCs
No. of pressor or inotropea
AKI characteristics
Baseline Scr, mg/dLb
Baseline eGFR, mL/min/1.73 m2b
Peak Scr, mg/dL

Total

Recovery Group

No Recovery Group

(N =111)

(n = 45)

(n = 66)

P

59 [47-67]
69 (62%)
101 (91%)
30.5 [24.5-39.1]

55 [44-65]
28 (62%)
41 (91%)
30.7 [24.1-35.9]

63 [49-70]
41 (62%)
60 (91%)
30.5 [25.0-40.7]

0.08
>0.99
0.69
0.53

33.5 (11.4)
67 (60%)
69 (62%)
21 (19%)
37 (33%)
53 (48%)
43 (39%)
90 (81%)
90 (81%)

30.0 (13.0)
26 (58%)
30 (67%)
7 (16%)
17 (38%)
20 (44%)
19 (42%)
35 (78%)
35 (78%)

36.1 (9.5)
41 (62%)
39 (59%)
14 (21%)
20 (30%)
33 (50%)
24 (36%)
55 (83%)
55 (83%)

0.01
0.79
0.54
0.62
0.54
0.70
0.67
0.63
0.63

24.3 [16.3-36.2]
90 (81%)
5.6 [2.6-15.2]
7.8 (3.12)
63 (57%)
50 (45%)
94 (85%)
3.0 [2.0-8.0]
2.0 [1.0-3.0]

22.1 [17.0- 33.2]
41 (91%)
6.1 [2.9-19.2]
8.3 (3.07)
31 (69%)
25 (56%)
41 (91%)
3.0 [2.0-6.8]
2.0 [2.0-3.0]

26.7 [16.3- 39.3]
49 (74%)
4.3 [2.6-7.9]
7.4 (3.13)
32 (48%)
25 (38%)
53 (80%)
4.0 [2.3-11.8]
2.0 [0.0-3.0]

0.28
0.05
0.17
0.13
0.05
0.10
0.20
0.05
0.34

2.4 [1.4-3.8]
26.9 [16.5-54.6]
6.2 [5.0-7.7]

2.2 [1.3-2.9]
29.5 [22.3-54.8]
6.1 [4.6-7.6]

2.7 [1.5-6.0]
19.1 [12.0-39.9]
6.2 [5.1-8.0]

0.09
0.06
0.47

Note: Values expressed as median [interquartile 1-interquartile 3] or number (percent).
Abbreviations: AKI, acute kidney injury; BMI, body mass index; CAD, coronary artery disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary
disease; eGFR, estimated glomerular ﬁltration rate; ICU, intensive care unit; pRBC, packed red blood cell; Scr, serum creatinine; SOFA, Sequential Organ Failure
Assessment.
a
Only determined for patients admitted to the ICU.
b
Only determined for patients with measured baseline Scr.

Clinical Parameters Associated With Kidney
Recovery
Patients who did not recover kidney function were older
(median age, 63 vs 55 years) and had more comorbidity as
graded by the Elixhauser score (mean score, 36.1 vs 30.0;
P = 0.01) when compared with those who recovered
kidney function. Further, patients who did not recover
kidney function had lower baseline estimated glomerular
filtration rates (median, 19.1 vs 29.5 mL/min/1.73 m2)
than those who recovered kidney function (Table 1). Patients who did not recover kidney function received more
packed red blood cell (pRBC) transfusions during AKI-D
hospitalization than those who recovered (median, 4.0
vs 3.0 units; P = 0.05). There were no major differences in
acute illness parameters, duration/type of KRT, and the
incidence of intradialytic hypotension between patients
who recovered versus did not recover kidney function
(Tables 1 and 2).
Kidney Med Vol 3 | Iss 6 | November/December 2021

In multivariable analysis, the exposure to each 1-unit
transfusion of pRBCs during hospitalization was independently associated with lack of kidney function recovery at

Figure 2. Kidney recovery outcomes of patients with acute kidney injury requiring dialysis discharged on hemodialysis within
the ﬁrst 90 days following hospital discharge.
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Figure 3. Kidney recovery outcomes of patients with acute kidney injury requiring dialysis discharged on hemodialysis according to
intervals of 30, 60, and 90 days following hospital discharge.

90 days postdischarge (adjusted odds ratio [OR], 1.15;
95% CI, 1.01-1.33; P = 0.047; Table 3). Patients who
received pRBC transfusions had higher Elixhauser comorbidity scores and more frequently had anemia on admission. These patients had prolonged hospitalizations, longer
durations of HD requirement, and more frequent need for
vasoactive drugs when compared with patients who did
not receive pRBC transfusions during hospitalization
(Tables S1 and S2). Every 1-unit increase in Elixhauser
score was also independently associated with lack of kidney function recovery at 90 days postdischarge (adjusted
OR, 1.05; 95% CI, 1.01-1.10; P = 0.013; Table 3). When
discrete-time survival-adjusted probabilities were determined, kidney functional recovery was estimated at 36.7%
at 30 days, 27.4% at 60 days, and only 6.3% at 90 days.
Covariates in the model, including exposure to pRBCs
during hospitalization and Elixhauser score, were only
associated with kidney functional recovery in the latest
period of evaluation (60-90 days postdischarge; P = 0.01;
Table S3).

DISCUSSION
Survivors of AKI-D discharged from the hospital with
ongoing need of outpatient HD constitute a growing
population in the nephrology outpatient practice.17,18 In
this cohort, at least 1 of 3 survivors of AKI-D were alive
and dialysis independent within the first 90 days after
hospital discharge. This study is the first to prospectively
examine a cohort of survivors of AKI-D discharged to
outpatient dialysis or rehabilitation facilities for continuation of HD care after January 2017, a pivotal time during
which the provision of HD for patients with AKI was
newly approved for reimbursement in outpatient dialysis
facilities in the United States.
Other studies have also evaluated kidney recovery
following discharge in patients with AKI-D. Pajewski
et al19 reported a kidney recovery rate of 43%, which is
similar to our study. However, only patients discharged to
a hospital-affiliated dialysis unit were included.19 Gautam
et al20 reported a kidney recovery rate of 42% in their

Figure 4. Kidney recovery outcomes of patients with acute kidney injury requiring dialysis discharged on hemodialysis to (A) outpatient dialysis facilities and (B) rehabilitation facilities.
920
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Table 2. In-Hospital Kidney Replacement Therapy Characteristics According to Kidney Recovery Status

CKRT
Total days of CKRT
HD
Total days of HD
Total days of CKRT + HD
Intradialytic hypotension per CRRT-day
Intradialytic hypotension per HD-session

Total

Recovery Group

No Recovery Group

(N =111)
53 (48%)
7.01 [4.53-14.62]
108 (97%)
15.66 [10.22-23]
18.97 [12.44-30.18]
2.69 [1.91-3.9]
2.33 [0.21-8.34]

(n = 45)
24 (53%)
6.21 [4.01-10.86]
44 (98%)
13.91 [10.75-22.2]
18.79 [13.03-28.11]
3.05 [2.06-3.63]
2.47 [0.11-9.24]

(n = 66)
29 (44%)
7.96 [4.82-14.85]
64 (97%)
17.33 [10.1-24.12]
19.07 [11.24-32.91]
2.63 [1.22-3.98]
2.31 [0.24-7.09]

P
0.44
0.26
0.80
0.44
0.83
0.43
0.89

Note: Values expressed as median [interquartile 1-interquartile 3] or number (percent).
Abbreviations: CKRT, continuous kidney replacement therapy; HD, hemodialysis.

hospital-based dialysis unit. McAdams et al4 evaluated
exclusively patients with AKI-D discharged to a hospitalaffiliated rehabilitation facility and reported a kidney recovery rate of 65.8%. We also observed a higher kidney
recovery rate in patients receiving HD initially in rehabilitation facilities when compared with outpatient dialysis
units. This could be related to more frequent evaluations
by clinicians and better monitoring of kidney function (eg,
urine output and laboratory testing) when patients are
admitted to these facilities in comparison to the ambulatory setting. However, selection bias for acceptance into
these facilities (healthier patients accepted while sicker
patients rejected) may also play a role in the interpretation
of these findings and requires further investigation.
Since CMS changes in January 2017 supporting the
provision of HD for AKI in outpatient dialysis facilities,
patients with AKI-D represent a growing population
without standardized care, in part due to lack of evidencebased practices focused on patient-centered management.
Recent retrospective studies of Medicare/Medicaid databases report that patients with AKI treated in community
dialysis centers represent 2.7% of the whole dialysis population. The incidence of kidney recovery defined by
dialysis independence was reported as low as 17% and up
to 35%. One should note that in these studies, AKI-D
diagnosis and kidney recovery outcome were based on
Medicare/Medicaid claims and the US Renal Data System,

Table 3. Multivariable Logistic Regression Model of Kidney
Recovery (dependent variable) and Relevant Clinical
Parameters (independent variables)
Parameter
Elixhauser score, per 1-unit
increase
Baseline eGFR, per 1-unit
increase
ICU admission
Sepsis
Transfusion of pRBCs, per 1
unit

Odds Ratio 95% CI
P
1.05
1.01-1.10 0.01
0.98

0.96-1.00 0.08

0.27
0.44
1.15

0.07-0.83 0.03
0.18-1.06 0.07
1.01-1.33 0.05

Abbreviations: eGFR, estimated glomerular ﬁltration rate; pRBCs, packed red
blood cells.

Kidney Med Vol 3 | Iss 6 | November/December 2021

which is a methodology susceptible to misclassification
and selection bias.17,18,21
Numerous clinical conditions and exposures could play
a role in kidney recovery after AKI-D. These factors could
be patient or dialysis specific, with some being potentially
modifiable and others not. Prior studies have identified
heart disease, diabetes, chronic liver disease, baseline
kidney function, and urine output at hospital discharge as
conditions/parameters associated with kidney recovery or
independence of KRT.20,22 In our cohort, we found that
patients with AKI-D who did not recover kidney function
were older and had a higher burden of comorbidity and
lower baseline kidney function when compared with their
counterparts.
The presence of anemia and exposure to blood transfusions are clinical factors that may also influence kidney
recovery. Lee et al22 found that patients with AKI-D and
hemoglobin levels ≥ 12 g/dL had a 53% kidney recovery
rate compared with 39% in those with hemoglobin
levels < 12 g/dL. Similarly, McAdams et al4 found that
patients with AKI-D and anemia had decreased chances of
kidney recovery, with anemia being defined similarly to
our study. In a cohort of patients undergoing transcatheter
aortic valve replacement, Merchant et al23 found a 67%
greater chance of incident AKI with each 1-unit exposure
to pRBC transfusion. In our cohort, we found that exposure to pRBC transfusions during hospitalization adversely
and independently associated with kidney recovery at 90
days postdischarge, and that patients who required pRBC
transfusions had more frequently anemia on admission.
The toxic effect of pRBC transfusions can be due to
functional alterations in RBCs during storage, which may
result in decreased oxygen delivery. Furthermore, hemolysis during storage or transfusion can result in an increase
in free hemoglobin and iron catabolism that could damage
the kidney microvasculature.23,24 The role of anemia and/
or pRBC transfusions as surrogate markers of acuity of
illness versus risk factors involved in the pathobiology of
AKI needs to be further investigated.
Prior studies have suggested that intradialytic hypotension
has adverse effects on kidney recovery.4,10 Our study found
no salient differences in intradialytic hypotension events
among patients with versus without kidney recovery.
921
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Figure 5. Blood pressure variability during the period of in-hospital renal replacement therapy in a patient who (A) recovered kidney
function and (B) did not recover kidney function. Red tracks denote systolic blood pressure measurements and blue tracks denote
diastolic blood pressure measurements. Abbreviations: CRRT, continuous renal replacement therapy; HD, hemodialysis.

However, one should note that these BP parameters were
available only during the period of hospitalization and not
following hospital discharge. Further, BP parameters during
KRT are dynamic and may require more advanced methods
for evaluation, particularly if BP variability is a concern
during KRT (Fig 5). The latter has been extensively studied
in CKD populations because visit-to-visit BP variability has
been associated with increased risk for progression to kidney
failure and cardiovascular disease.25-27 Therefore, more
investigation into BP parameters, including BP data from the
hospital and outpatient dialysis facilities, is needed to better
elucidate whether prevention of intradialytic hypotension
represents a modifiable risk factor for kidney recovery in
patients with AKI-D.
There is a dire need to study interventions for patients
with AKI-D. Survivors of AKI-D who progressed to kidney
failure were shown to have higher mortality and increased
heart failure/acute coronary syndrome hospitalizations
when compared with patients who developed kidney
failure not due to AKI-D.9 Hsu et al28 found that patients
who had an abrupt decline in kidney function requiring
HD had 3-fold increased risk for death within the first year
when compared with patients with progressive deterioration of kidney function. Patients with AKI-D who recovered kidney function had decreased mortality than those in
whom AKI-D progressed to kidney failure.9 These findings
highlight the importance of promoting kidney recovery in
patients with AKI-D. As the population of patients with
AKI-D grows within community dialysis centers, it is
becoming imperative to identify patients who are more
922

likely to recover and to develop treatment protocols to best
promote recovery of kidney function in these patients.
Our study has some limitations. This is a single-center
prospective cohort study with inherent selection bias
given that patients included were survivors of AKI-D
eligible for outpatient HD for AKI management as part of
Medicare/Medicaid services. Further, given that many
patients were seen by community nephrology providers in
multiple HD units, postdischarge data related to Scr levels
and creatinine clearance measurements/trajectories were
not available for evaluation. Moreover, postdischarge
outpatient information regarding HD prescription (dose/
frequency), ultrafiltration management, dialysis access, BP
measurements, medications, HD compliance, or complication events from outpatient HD units was also not
available for evaluation.
Our study also has unique strengths. This is the first
study to prospectively and longitudinally analyze the
incidence of kidney recovery in a heterogeneous population of survivors of AKI-D who received HD treatment in
community dialysis or rehabilitation facilities after the
CMS policy change regarding reimbursement. Furthermore, all study outcomes were adjudicated by telephone
calls to outpatient dialysis centers and/or patients and
comprehensive chart review and not based on Medicare/
Medicaid claims, which reduces possible misclassification
bias. Finally, several clinical parameters during the index
AKI-D hospitalization were obtained and analyzed to
identify clinical factors that should be further investigated
for AKI-D risk-classification of kidney recovery and to
Kidney Med Vol 3 | Iss 6 | November/December 2021
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underpin possible interventions on potentially modifiable
risk factors.
At least 1 of 3 survivors of AKI-D discharged with
ongoing HD need survived and recovered kidney
function sufficiently to be independent of KRT within
the first 90 days postdischarge. Most AKI-D survivors
recovered kidney function in the first 30 days
following discharge, an observation that underpins a
critical window for surveillance and intervention.
Older patients and those with more comorbid conditions and lower baseline kidney function were less
likely to recover kidney function. Exposure to pRBC
transfusions during hospitalization was independently
associated with lower chances of kidney recovery at 90
days postdischarge. Future studies should elucidate
patient- and KRT-specific parameters that can riskclassify kidney recovery, with the goals of developing
informative risk prediction tools, as well as identifying
best clinical practices to promote kidney recovery in
the inpatient and outpatient settings.
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What are
the kidney
patients
What
question
is outcomes
the studyoftrying
towith AKI
requiring
answer?dialysis (AKI-D)?
Prospective study
Single center

Patients with AKI -D
n = 111

Discharged to
outpatient HD
centers

Outcomes

Rate of kidney
recovery

45 (41%)
patients
recovered
kidney function

Kidney recovery
Alive & free of HD

49 (44%)
Developed ESKD
requiring KRT

Jan 2017 to Nov 2019

17 (15%) died or
initiated hospice

Parameters associated with
kidney recovery

Time -to recovery
Recovery of kidney
function

25 (55.5%)
within 30 days

Adjusted probability
of recovery

36.7 %

Less kidney recovery
in AKI-D was seen in
• Older age
• More
comorbidities

16 (35.5%)
within 30-60
days

27.4 %

4 (9%) within
60-90 days

6.3 %

• Lower eGFR at
baseline
• More blood
transfusions

Conclusion: At least one -third of AKI -D survivors recovered kidney function within

Reference : Jordan M, Ortiz -Soriano V, Pruitt A et al . Kidney

the first 90 days of discharge. Future studies should elucidate clinical parameters that
can inform risk -classification and interventions to promote kidney recovery in this
vulnerable and growing population.

recovery in patients with AKI treated in outpatient hemodialysis or
rehabilitation facilities. Kidney Medicine, 2021 .
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